ERAS · All filings · Read this filing
What changed 10-Q
Item 2. Unregistered Sales of Equity Securities
2023-05-15 compared with 2022-11-09 · 1 added, 1 removed, 18 unchanged (10% of the section changed)
12 unchanged sentences
No offering costs were paid or are payable, directly or indirectly, to our directors or officers, to persons owning 10% or more of any class of our equity securities or to any of our affiliates.
−Removed: As of September 30, 2022, we have used approximately $133.1 million of the proceeds from our IPO for general corporate purposes, including to fund the research and development of ERAS-007, ERAS-601 and our other RAS/MAPK pathway-focused pipeline programs.
+Added: As of March 31, 2023, we have used approximately $210.2 million of the proceeds from our IPO for general corporate purposes, including to fund the research and development of ERAS-007, ERAS-601 and our other RAS/MAPK pathway-focused pipeline programs.
There has been no material change in the planned use of such proceeds from that described in the prospectus for our IPO.
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.